Efficacy, recovery, and safety of RBCs from autologous placental blood: clinical experience in 52 newborns.
Another optimistic article about the use of autologous placental blood in order to reduce exposure to allogeneic donor blood. A benefit was observed in almost 60% of neonates with a birth weight of 1000 to 2500 g and in those requiring surgery, but not in the very premature neonates (< 1000 g). No adverse effects […]
Usefulness of cord-blood harvesting for autologous transfusion in surgical newborns with antenatal diagnosis of congenital anomalies.
In connection with this study, one may wonder how often, in those children needing blood transfusions, the volume of cord blood collected will be sufficient to avoid allogeneic transfusions. Besides, the risk of bacteria contamination is clearly higher than the risk associated with allogeneic blood, particularly under routine conditions. – V. Kretschmer.